Artal Group’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-884,214
Closed -$12.4M 114
2024
Q1
$12.4M Buy
+884,214
New +$12.4M 0.32% 37
2022
Q4
Sell
-33,333
Closed -$301K 128
2022
Q3
$301K Hold
33,333
0.01% 126
2022
Q2
$100K Hold
33,333
0.01% 131
2022
Q1
$224K Hold
33,333
0.01% 133
2021
Q4
$180K Hold
33,333
﹤0.01% 144
2021
Q3
$295K Buy
+33,333
New +$295K 0.01% 139